This inventor holds 1 USPTO granted patent. Top assignee: Nanjing Geneleap Biotechnology Co., Ltd.. Active years: 2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2024
Title: Jaewoo Lee: Innovator in mRNA Technology
Introduction: Jaewoo Lee is a prominent inventor based in Cary, NC (US). He has made significant contributions to the fields of mRNA vaccines, mRNA therapy, and gene therapy. His innovative work focuses on enhancing gene transcription and translation efficiency through the modification of 5′UTR sequences.
Latest Patents: Jaewoo Lee holds a patent titled "Modification of gene transcription and translation efficiency by 5′UTR sequence variation." This invention pertains to the use of gene expression vectors or PCR amplicons that contain various 5′UTR sequences followed by coding sequences. It aims to improve the in vitro and in vivo production of mRNA or proteins of interest. He has 1 patent to his name.
Career Highlights: Jaewoo Lee is currently employed at Nanjing Geneleap Biotechnology Co., Ltd., where he continues to advance research in genetic engineering and therapeutic applications. His work is pivotal in the development of innovative solutions in the biotechnology sector.
Collaborations: Some of his notable coworkers include Xiaoyao Hao and Dan Tse, who contribute to the collaborative efforts in their research endeavors.
Conclusion: Jaewoo Lee's contributions to mRNA technology and gene therapy highlight his role as an influential inventor in the biotechnology field. His innovative patent work continues to pave the way for advancements in medical therapies.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile